Evaluation of aggressiveness and neoadjuvant chemotherapy in patients with squamous cell carcinoma of head and neck by energy spectrum CT and MRI functional imaging

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300073227

Enrollment

Unknown

Registered

2023-07-04

Start date

2021-12-10

Completion date

Unknown

Last updated

2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

squamous cell carcinoma of head and neck

Interventions

Gold Standard:The pathological diagnosis was head and neck squamous cell carcinoma.

Index test:sensitivity

specificity

accuracy

positive predictive value

negative predictive value

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Surgical excision (interval between surgical excision and imaging examination < 2 weeks), who were first pathologically diagnosed with HNSCC.

Exclusion criteria

Exclusion criteria: 1) Previous history of chemotherapy and/or radiotherapy; 2) No surgical resection; 3) The interval between surgical resection and imaging examination > 2 weeks; 4) Obvious artifacts; 5) Contraindications to CT and MRI scanning.

Design outcomes

Primary

Measure	Time frame
Dual-energy CT and MR function sequence parameters;Accuracy ;Sensitivity ;Specificity ;Positive predicative value;Negative predictive value;	—

Countries

China

Contacts

Public ContactXiaohui Duan

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

duanxh5@mail.sysu.edu.cn+86 135 1276 2365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026